1. Home
  2. LINK vs MNOV Comparison

LINK vs MNOV Comparison

Compare LINK & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Interlink Electronics Inc.

LINK

Interlink Electronics Inc.

HOLD

Current Price

$2.97

Market Cap

59.5M

Sector

Technology

ML Signal

HOLD

Logo Medicinova Inc

MNOV

Medicinova Inc

N/A

Current Price

$1.40

Market Cap

66.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LINK
MNOV
Founded
1984
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
59.5M
66.9M
IPO Year
2007
2004

Fundamental Metrics

Financial Performance
Metric
LINK
MNOV
Price
$2.97
$1.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$8.67
$7.50
AVG Volume (30 Days)
17.4K
22.1K
Earning Date
05-11-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
45.83
N/A
EPS
N/A
N/A
Revenue
$11,890,000.00
$2,360,807.00
Revenue This Year
$43.26
N/A
Revenue Next Year
$19.16
$180.00
P/E Ratio
N/A
N/A
Revenue Growth
1.81
194.15
52 Week Low
$2.66
$1.17
52 Week High
$15.15
$1.96

Technical Indicators

Market Signals
Indicator
LINK
MNOV
Relative Strength Index (RSI) 50.30 51.28
Support Level $3.01 $1.40
Resistance Level $3.38 $1.43
Average True Range (ATR) 0.22 0.04
MACD 0.01 0.00
Stochastic Oscillator 39.66 41.18

Price Performance

Historical Comparison
LINK
MNOV

About LINK Interlink Electronics Inc.

Interlink Electronics Inc is a sensor and printed electronics company operating in two principal sensor technology divisions: force/touch sensors, and gas and environmental sensors. It designs, develops, manufactures and sells a range of force-sensing and gas-sensing technologies that incorporate its proprietary materials technology, firmware and software into a portfolio of standard sensor-based products and custom sensor system solutions. Its force-sensing products and solutions include sensor components, subassemblies, modules products that support effective, efficient cursor control and novel three-dimensional user inputs. Its Human Machine Interface technology platforms are deployed in a wide range of markets including consumer electronics, automotive, industrial, and medical.

About MNOV Medicinova Inc

MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.

Share on Social Networks: